US Equity
INCY
— INCYTE CORPORATIONIncyte is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs, primarily for oncology and inflammation.
💰 Market cap: $23.75B📍 1801 Augustine Cut-Off, WILMINGTON, DE, 19803 US🏷️ Pharmaceuticals💵 Previous close: $117.67🔢 5,036 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $117.67 |
| 2026-07-23 | $116.69 |
| 2026-07-22 | $115.79 |
| 2026-07-21 | $117.39 |
| 2026-07-20 | $115.65 |
| 2026-07-17 | $117.25 |
| 2026-07-16 | $116.65 |
| 2026-07-15 | $115.09 |
| 2026-07-14 | $114.88 |
| 2026-07-13 | $114.23 |
| 2026-07-10 | $116.71 |
| 2026-07-09 | $118.52 |
| 2026-07-08 | $117.26 |
| 2026-07-07 | $118.05 |
| 2026-07-06 | $115.62 |
| 2026-07-02 | $116.86 |
| 2026-07-01 | $113.81 |
| 2026-06-30 | $113.36 |
| 2026-06-29 | $114.66 |
| 2026-06-26 | $113.75 |
| 2026-06-25 | $107.53 |
| 2026-06-24 | $108.46 |
| 2026-06-23 | $104.40 |
| 2026-06-22 | $103.66 |
| 2026-06-18 | $98.22 |
| 2026-06-17 | $98.99 |
| 2026-06-16 | $99.75 |
| 2026-06-15 | $101.98 |
| 2026-06-12 | $108.53 |
| 2026-06-11 | $107.83 |
| 2026-06-10 | $105.39 |
| 2026-06-09 | $103.23 |
| 2026-06-08 | $100.64 |
| 2026-06-05 | $102.38 |
| 2026-06-04 | $101.24 |
| 2026-06-03 | $97.98 |
| 2026-06-02 | $92.24 |
| 2026-06-01 | $95.59 |
| 2026-05-29 | $96.74 |
| 2026-05-28 | $97.50 |
| 2026-05-27 | $97.34 |
| 2026-05-26 | $97.10 |
| 2026-05-22 | $97.16 |
| 2026-05-21 | $97.41 |
| 2026-05-20 | $97.08 |
| 2026-05-19 | $95.60 |
| 2026-05-18 | $95.19 |
| 2026-05-15 | $95.31 |
| 2026-05-14 | $97.63 |
| 2026-05-13 | $98.82 |
| 2026-05-12 | $99.13 |
| 2026-05-11 | $100.32 |
| 2026-05-08 | $98.56 |
| 2026-05-07 | $97.77 |
| 2026-05-06 | $99.85 |
| 2026-05-05 | $97.47 |
| 2026-05-04 | $97.14 |
| 2026-05-01 | $96.91 |
| 2026-04-30 | $95.27 |
| 2026-04-29 | $99.10 |
| 2026-04-28 | $97.74 |